NYSE:DLB - New York Stock Exchange, Inc. - US25659T1079 - Common Stock - Currency: USD
72.98
+0.7 (+0.97%)
The current stock price of DLB is 72.98 USD. In the past month the price decreased by -3.43%. In the past year, price decreased by -7.89%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
MSFT | MICROSOFT CORP | 37.56 | 3612.21B | ||
ORCL | ORACLE CORP | 34.33 | 580.59B | ||
NOW | SERVICENOW INC | 67.34 | 202.92B | ||
PANW | PALO ALTO NETWORKS INC | 64.55 | 135.57B | ||
CRWD | CROWDSTRIKE HOLDINGS INC - A | 131.85 | 122.50B | ||
FTNT | FORTINET INC | 40.93 | 78.95B | ||
ZS | ZSCALER INC | 94.94 | 48.03B | ||
CHKP | CHECK POINT SOFTWARE TECH | 23.94 | 24.21B | ||
CYBR | CYBERARK SOFTWARE LTD/ISRAEL | 121.8 | 19.97B | ||
GEN | GEN DIGITAL INC | 12.98 | 17.87B | ||
RBRK | RUBRIK INC-A | N/A | 17.35B | ||
MNDY | MONDAY.COM LTD | 72.72 | 14.66B |
Dolby Laboratories, Inc. engages in the provision of audio and imaging technologies. The company is headquartered in San Francisco, California and currently employs 2,080 full-time employees. The company went IPO on 2005-02-17. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The firm's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. The company also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment.
DOLBY LABORATORIES INC-CL A
1275 Market Street
San Francisco CALIFORNIA 94103 US
CEO: Kevin J. Yeaman
Employees: 2080
Phone: 14155580200
The current stock price of DLB is 72.98 USD. The price increased by 0.97% in the last trading session.
The exchange symbol of DOLBY LABORATORIES INC-CL A is DLB and it is listed on the New York Stock Exchange, Inc. exchange.
DLB stock is listed on the New York Stock Exchange, Inc. exchange.
8 analysts have analysed DLB and the average price target is 99.45 USD. This implies a price increase of 36.27% is expected in the next year compared to the current price of 72.98. Check the DOLBY LABORATORIES INC-CL A stock analysts ratings, price target forecast and up-and down grades for more detailed information.
DOLBY LABORATORIES INC-CL A (DLB) has a market capitalization of 7.01B USD. This makes DLB a Mid Cap stock.
DOLBY LABORATORIES INC-CL A (DLB) currently has 2080 employees.
DOLBY LABORATORIES INC-CL A (DLB) has a support level at 71.73 and a resistance level at 74.43. Check the full technical report for a detailed analysis of DLB support and resistance levels.
The Revenue of DOLBY LABORATORIES INC-CL A (DLB) is expected to grow by 5.04% in the next year. Check the estimates tab for more information on the DLB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
DOLBY LABORATORIES INC-CL A (DLB) has a dividend yield of 1.8%. The yearly dividend amount is currently 1.2. Check the full fundamental report for a detailed analysis of DLB dividend history, reliability and sustainability.
DOLBY LABORATORIES INC-CL A (DLB) will report earnings on 2025-08-05, after the market close.
The PE ratio for DOLBY LABORATORIES INC-CL A (DLB) is 18.25. This is based on the reported non-GAAP earnings per share of 4 and the current share price of 72.98 USD. Check the full fundamental report for a full analysis of the valuation metrics for DLB.
The outstanding short interest for DOLBY LABORATORIES INC-CL A (DLB) is 1.85% of its float. Check the ownership tab for more information on the DLB short interest.
ChartMill assigns a fundamental rating of 7 / 10 to DLB. DLB gets an excellent profitability rating and is at the same time showing great financial health properties.
Over the last trailing twelve months DLB reported a non-GAAP Earnings per Share(EPS) of 4. The EPS increased by 14.94% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 19.44% | ||
ROA | 7.95% | ||
ROE | 9.97% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to DLB. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 5.52% and a revenue growth 5.04% for DLB